Your browser doesn't support javascript.
loading
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.
Salomé, Bérengère; Sfakianos, John P; Ranti, Daniel; Daza, Jorge; Bieber, Christine; Charap, Andrew; Hammer, Christian; Banchereau, Romain; Farkas, Adam M; Ruan, Dan Fu; Izadmehr, Sudeh; Geanon, Daniel; Kelly, Geoffrey; de Real, Ronaldo M; Lee, Brian; Beaumont, Kristin G; Shroff, Sanjana; Wang, Yuanshuo A; Wang, Ying-Chih; Thin, Tin Htwe; Garcia-Barros, Monica; Hegewisch-Solloa, Everardo; Mace, Emily M; Wang, Li; O'Donnell, Timothy; Chowell, Diego; Fernandez-Rodriguez, Ruben; Skobe, Mihaela; Taylor, Nicole; Kim-Schulze, Seunghee; Sebra, Robert P; Palmer, Doug; Clancy-Thompson, Eleanor; Hammond, Scott; Kamphorst, Alice O; Malmberg, Karl-Johan; Marcenaro, Emanuela; Romero, Pedro; Brody, Rachel; Viard, Mathias; Yuki, Yuko; Martin, Maureen; Carrington, Mary; Mehrazin, Reza; Wiklund, Peter; Mellman, Ira; Mariathasan, Sanjeev; Zhu, Jun; Galsky, Matthew D; Bhardwaj, Nina.
Afiliação
  • Salomé B; The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Sfakianos JP; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Ranti D; The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Urology, Icahn School of Medi
  • Daza J; The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Urology, Icahn School of Medi
  • Bieber C; The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Urology, Icahn School of Medi
  • Charap A; The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Urology, Icahn School of Medi
  • Hammer C; Department of Cancer Immunology, Genentech, South San Francisco, CA 94080, USA; Department of Human Genetics, Genentech, South San Francisco, CA 94080, USA.
  • Banchereau R; Department of Oncology Biomarker Development, Genentech, South San Francisco, CA 94080, USA.
  • Farkas AM; The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Ruan DF; The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Izadmehr S; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Geanon D; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Kelly G; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • de Real RM; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Lee B; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Beaumont KG; Center for Advanced Genomics Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Shroff S; Center for Advanced Genomics Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Wang YA; The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Wang YC; Center for Advanced Genomics Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Thin TH; Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Garcia-Barros M; Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Hegewisch-Solloa E; Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
  • Mace EM; Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
  • Wang L; Center for Advanced Genomics Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Sema4, a Mount Sinai Venture, Stamford, CT 06902, USA.
  • O'Donnell T; The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Chowell D; The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Fernandez-Rodriguez R; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Skobe M; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Taylor N; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Kim-Schulze S; The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Sebra RP; Center for Advanced Genomics Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Sema4, a Mount Sinai Venture, Stamford, CT 06902, USA; Black Family Stem Cell Inst
  • Palmer D; AstraZeneca, Oncology R & D Unit, Gaithersburg, MD 20878, USA.
  • Clancy-Thompson E; AstraZeneca, Oncology R & D Unit, Gaithersburg, MD 20878, USA.
  • Hammond S; AstraZeneca, Oncology R & D Unit, Gaithersburg, MD 20878, USA.
  • Kamphorst AO; The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Malmberg KJ; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Marcenaro E; Department of Experimental Medicine, University of Genoa, Genoa, Italy.
  • Romero P; Department of Oncology UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
  • Brody R; Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Viard M; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.
  • Yuki Y; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.
  • Martin M; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.
  • Carrington M; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
  • Mehrazin R; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Wiklund P; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Mellman I; Department of Cancer Immunology, Genentech, South San Francisco, CA 94080, USA.
  • Mariathasan S; Department of Oncology Biomarker Development, Genentech, South San Francisco, CA 94080, USA.
  • Zhu J; Center for Advanced Genomics Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Sema4, a Mount Sinai Venture, Stamford, CT 06902, USA.
  • Galsky MD; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Bhardwaj N; The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: nina.bhardwaj@
Cancer Cell ; 40(9): 1027-1043.e9, 2022 09 12.
Article em En | MEDLINE | ID: mdl-36099881
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Subfamília C de Receptores Semelhantes a Lectina de Células NK Limite: Humans Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Subfamília C de Receptores Semelhantes a Lectina de Células NK Limite: Humans Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos